Role of vacuolating cytotoxin VacA and cytotoxin-associated antigen CagA of Helicobacter pylori in the progression of gastric cancer

Molecular and Cellular Biochemistry

Volumn 396, Issue 1-2, 2014, Pages 23-32

  Ki, Mi Ran ^a,c   Hwang, Meeyul ^a   Kim, Ah Young ^a   Lee, Eun Mi ^a   Lee, Eun Joo ^a   Lee, Myeong Mi ^a   Sung, Soo Eun ^a   Kim, Sang Hyeob ^a   Lee, Hye Seung ^b   Jeong, Kyu Shik ^a  

^a Kyungpook National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Korea University   (South Korea)

Author keywords

CagA; Gastric cancer; Helicobacter pylori; Precancerous lesion; VacA

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; VACA PROTEIN, HELICOBACTER PYLORI;

ADULT; AGE; AGED; BIOPSY; COMPLICATION; FEMALE; GASTRIC MUCOSA; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE; MALE; METABOLISM; METAPLASIA; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; PRECANCER; STOMACH NEOPLASMS;

ADULT; AGE FACTORS; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOPSY; FEMALE; GASTRIC MUCOSA; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 84907591690     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2138-8     Document Type: Article

References (56)

1. Blaser MJ, Perez-Perez GI, Kleanthous H et al (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55(10):2111-2115
2. Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1(8390):1311-1315
3. Helicobacter pylori in peptic ulcer disease (1994) NIH Consens Statement 12(1):1-23
4. Kodama M, Murakami K, Okimoto T et al (2012) Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation. Digestion 85(2):126-130
5. Pimanov SI, Makarenko EV, Voropaeva AV et al (2008) Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. J Gastroenterol Hepatol 23(11):1666-1671
6. Correa P (1992) Human gastric carcinogenesis: multistep and multifactorial process. Cancer Res 52(24):6735-6740
7. Leung WK, Ng EK, Chan WY, Auyeung AC et al (2005) Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients. Cancer Epidemiol Biomark Prev 14(12):2982-2986
8. Lamb A, Chen LF (2013) Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer. J Cell Biochem 114(3):491-497
9. Houghton J, Wang TC (2005) Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 128(6):1567-1578
10. Uemura N, Okamoto S, Yamamoto S et al (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345(11):784-789
11. Sepulveda AR (2013) Helicobacter, inflammation, and gastric cancer. Curr Pathobiol Rep 1(1):9-18
12. González CA, Figueiredo C, Lic CB et al (2011) Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Am J Gastroenterol 106(5):867-874
13. Atherton JC, Cao P, Peek RM Jr et al (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270(30):17771-17777
14. Greenfield LK, Jones NL (2013) Modulation of autophagy by Helicobacter pylori and its role in gastric carcinogenesis. Trends Microbiol 21(11):602-612
15. Zambon CF, Navaglia F, Basso D et al (2003) Helicobacter pylori babA, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol 56(4):287-291
16. Basso D, Zambon CF, Letley DP et al (2008) Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135(1):91-99
17. The eurohepygast study group (2002) Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study. Gut 50(6):779-785
18. Lee HS, Choe G, Kim WH et al (2006) Expression of Lewis antigens and their precursors in gastric mucosa: relationship with Helicobacter pylori infection and gastric carcinogenesis. J Pathol 209(1):88-94
19. Dixon MF, Genta RM, Yardley JH et al (1996) The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 20(10):1161-1181
20. Lee HS, Lee HK, Kim HS et al (2001) MUC1, MUC2, MUC5AC, and MUC6 expression in gastric carcinomas: their roles as prognostic indicators. Cancer 92(6):1427-1434
21. Ki MR, Lee HR, Goo MJ et al (2008) Differential regulation of ERK1/2 and p38 MAP kinases in VacA-induced apoptosis of gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 294(3):G635-G647
22. Ki MR, Hong IH, Park JK et al (2009) Potent neutralization of vacuolating cytotoxin (VacA) of Helicobacter pylori by immunoglobulins against the soluble recombinant VacA. Anticancer Res 29(6):2393-2402
23. Kimmel B, Bosserhoff A, Frank R et al (2000) Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect Immun 68(2):915-920
24. Asaka M, Kato M, Graham DY (2010) Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med 49(7):633-636
25. Maehata Y, Nakamura S, Fujisawa K et al (2012) Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc 75(1):39-46
26. Raider G, Fischer W, Haas R (2005) Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules. Curr Opin Microbiol 8(1):67-73
27. Leunk RD, Johnson PT, David BC et al (1988) Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 26(2):93-99
28. Galmiche A, Rassow J, Doye A et al (2000) The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J 19(23):6361-6370
29. Cover TL, Krishna US, Israel DA (2003) Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res 63(5):951-957
30. Boncristiano M, Paccani SR, Barone S et al (2003) The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J Exp Med 198(12):1887-1897
31. Gebert B, Fischer W, Weiss E et al (2003) Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301(5636):1099-1102
32. Supajatura V, Ushio H, Wada A et al (2002) Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 168(6):2603-2607
33. Yang I, Nell S, Suerbaum S (2013) Survival in hostile territory: the microbiota of the stomach. FEMS Microbiol Rev 37(5):736-761
34. Stein M, Bagnoli F, Halenbeck R et al (2002) c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 43(4):971-980
35. Segal ED, Cha J, Lo J et al (1999) Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA 96(25):14559-14564
36. De Luca A, Baldi A, Russo P et al (2003) Coexpression of Helicobacter pylori's proteins CagA and HspB induces cell proliferation in AGS gastric epithelial cells, independently from the bacterial infection. Cancer Res 63(19):6350-6356
37. von Herbay A, Rudi J (2000) Role of apoptosis in gastric epithelial turnover. Microsc Res Tech 48(5):303-311
38. Anagnostopoulos GK, Stefanou D, Arkoumani E et al (2005) Bax and Bcl-2 protein expression in gastric precancerous lesions: immunohistochemical study. J Gastroenterol Hepatol 20(11):1674-1678
39. Andl CD, Mizushima T, Nakagawa H et al (2003) Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem 278(3):1824-1830
40. Wang LJ, Chen SJ, Chen Z et al (2006) Morphological and pathologic changes of experimental chronic atrophic gastritis (CAG) and the regulating mechanism of protein expression in rats. J Zhejiang Univ 7(8):634-640
41. Tabassam FH, Graham DY, Yamaoka Y (2009) Helicobacter pylori activate epidermal growth factor receptor and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3 beta phosphorylation. Cell Microbiol 11(1):70-82
42. Ashktorab H, Daremipouran M, Wilson M et al (2007) Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer. Am J Gastroenterol 102(10):2135-2146
43. Keates S, Keates AS, Nath S et al (2005) Transactivation of the epidermal growth factor receptor by cag + Helicobacter pylori induces upregulation of the early growth response gene Egr-1 in gastric epithelial cells. Gut 54(10):1363-1369
44. Osborn M, Mazzoleni G, Santini D et al (1988) Villin, intestinal brush border hydrolases and keratin polypeptides in intestinal metaplasia and gastric cancer; an immunohistologic study emphasizing the different degrees of intestinal and gastric differentiation in signet ring cell carcinomas. Virchows Arch A Pathol Anat Histopathol 413(4):303-312
45. Renehan AG, O'Dwyer ST, Haboubi NJ et al (2002) Early cellular events in colorectal carcinogenesis. Colorectal Dis 4(2):76-89
46. Yokoyama K, Higashi H, Ishikawa S et al (2005) Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc Natl Aca Sci USA 102(27):9661-9666
47. Iijima K, Koike T, Sekine H et al (2009) Sustained epithelial proliferation in a functionally irreversible fundic mucosa after Helicobacter pylori eradication. J Gastroenterol 44(1):47-55
48. Karita M, Teramukai S, Matsumoto S et al (2005) Intracellular VacA is a valuable marker to predict whether Helicobacter pylori induces progressive atrophyic gastritis that is associated with the development of gastric cancer. Dig Dis Sci 50(1):56-64
49. Annibale B, Lahner E, Santucci A et al (2007) CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis. Helicobacter 12(1):23-30
50. Negrini R, Savio A, Poiesi C et al (1996) Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111(3):655-665
51. Amedei A, Bergman MP, Appelmelk BJ et al (2003) Molecular mimicry between Helicobacter pylori antigens and H+, K+-adenosine triphosphatase in human gastric autoimmunity. J Exp Med 198(8):1147-1156
52. Bergman MP, vandenbroucke-grauls CM, Appelmelk BJ et al (2005) The story so far: Helicobacter pylori and gastric autoimmunity. Int Rev Immunol 24(1-2):63-91
53. Dohmen K, Shigematsu H, Miyamoto Y et al (2002) Atrophic corpus gastritis and Helicobacter pylori infection in primary biliary cirrhosis. Dig Dis Sci 47(1):162-169
54. Goo MJ, Ki MR, Lee HR et al (2008) Primary biliary cirrhosis, similar to that in human beings, in a male C57BL/6 mouse infected with Helicobacter pylori. Eur J Ggastroenterol Hepatol 20(10):1045-1048
55. De Bolos C, Garrido M, Real FX (1995) MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 109(3):723-734
56. Gonzalez-Valencia G, Munoz-Perez L, Morales-Espinosa R et al (2008) Lewis antigen expression by Helicobacter pylori strains colonizing different resions of the stomach of individual patients. J Clin Microbiol 46(8):2783-2785